ClinicalTrials.gg
Enrolling by invitationNCT05903313Updated Jan 11, 2024

A Study to Evaluate Accuracy and Validity of the Chang Gung ECG Abnormality Detection Software

An observational study in Long QT Syndrome, Sinus Bradycardia and Sinus Tachycardia, sponsored by Chang Gung Memorial Hospital. Enrolling by invitation at 1 site in Taiwan. Open to participants aged 20 Years and older. Per ClinicalTrials.gov, last updated 2024-01-11.

Sponsored by Chang Gung Memorial Hospital · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2024, 2 years 9 months ago, but the record still lists the study as enrolling by invitation.
Study type
Observational
Model
Case-control
Time perspective
Retrospective
Enrollment
4,306
Ages
20 Years and older
Sex
All
01

Study summary

"Chang Gung ECG Abnormality Detection Software" is a is an artificial intelligence medical signal analysis software that detect whether patients have abnormal ECG signals of 14 diseases by static 12-lead ECG. The 14 diseases were

  • Long QT syndrome
  • Sinus bradycardia
  • Sinus Tachycardia
  • Premature atrial complexes
  • Premature ventricular complexes
  • Atrial Flutter, Right bundle branch block
  • Left bundle branch block
  • Left Ventricular hypertrophy
  • Anterior wall Myocardial Infarction
  • Septal wall Myocardial Infarction
  • Lateral wall Myocardial Infarction
  • Inferior wall Myocardial Infarction
  • Posterior wall Myocardial Infarction

The main purpose of this study is to verify whether "Chang Gung ECG Abnormality Detection Software" can correctly identify abnormal ECG signals among patients of 14 diseases. The interpretation standard is the consensus of 3 cardiologists. The results of the software analysis will be used to evaluate the performance of the primary and secondary evaluation indicators.

Read the detailed description

Detailed procedure:

  1. Sample source:

    This is a retrospective study, and the data comes from the Chang Gung Medical Research Database(CGRD) which was an database form 6 hospitals of Chang Gung Memorial hospital. We collected de-identified static 12-lead ECG data from the database during 2006.01.01\~2019.12.31, and the length of the ECG was 10 seconds.

  2. Sampling:

    In this experiment, the training dataset and the test dataset ECG were separated. Afterwards, the ECG signals are stratified according to the distribution as the test sample, and all abnormal ECG signals of 14 diseases will be independently sampled from the ECG database of the test set.

  3. Confirmation criteria:

    The ECG data will be preliminarily screened and selected by the inclusion and exclusion criteria and compiled serial numbers. Then, a cardiologist confirms that the sampling results of the ECG data do not include the exclusion criteria again.

  4. Physician interpretation:

    The ECG data will be converted into graphic files and submitted to 3 cardiologists for interpretation abnormal ECG signals of 14 related diseases. The results will be used as the standard of this study (Reference).

  5. Software interpretation:

    After confirming the test standard, input the ECG signal into Chang Gung ECG Abnormality Detection Software to analyze abnormal ECG signals of 14 diseases and interpret each ECG data.

  6. Statistical analysis:

After the software interpretation is completed, it will be compared with the results of the physician's interpretation and analyze the primary and secondary evaluation indicators.

02

Conditions studied

  • Long QT Syndrome
  • Sinus Bradycardia
  • Sinus Tachycardia
  • Premature Atrial Complexes
  • Premature Ventricular Complexes
  • Atrial Flutter
  • Right Bundle-Branch Block
  • Left Bundle-Branch Block
  • Left Ventricular Hypertrophy
  • Myocardial Infarction
03

In context

Long QT Syndrome

101 studies on the registry are indexed under Long QT Syndrome; 20 are open to participants now.

This study's planned enrollment of 4,306 is above the median of 150 across 53 observational studies indexed under Long QT Syndrome.

Browse Long QT Syndrome studies →

Lead sponsor

Chang Gung Memorial Hospital is the lead sponsor of 1,096 studies on the registry; 239 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This is a retrospective study, and the data comes from the Chang Gung Medical Research Database(CGRD) which was an database form 6 hospitals of Chang Gung Memorial hospital. According to inclusion and exclusion criteria, de-identified static 12-lead ECG data from the database during 2006.01.01\~2019.12.31 was collected, and the length of the ECG was 10 seconds.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Equal or greater than twenty years old.
  • Static 12-lead of General Electric MUSE XML format file.
  • The data comes from the static 12-lead electrocardiogram device of General Electric (model MAC5500).
  • The electrocardiogram signal is 500 Hz.
  • The Alternating current (AC) filter of the electrocardiogram signal is 60 Hz.
  • The resource of original diagnosis was a cardiologist.

Exclusion criteria

Exclusion Criteria:

  • Cases used in the model development process.
  • Lacks any electrode.
  • Contain any electrode lacks a segment.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ECG (electrocardiogram)

A recording of the heart’s electrical activity, taken with stickers on the chest, arms and legs. It takes a few minutes and does not hurt.

05

Study design

Observational model
Case-control
Time perspective
Retrospective
Enrollment
4,306 participants (estimated)
Patient registry
No

Groups and cohorts

  • Software diagnosis

    Software diagnosis with gold standard of 3 cardiologists' interpretation.

    Drug: Chang Gung ECG Abnormality Detection Software

Interventions

  • DrugChang Gung ECG Abnormality Detection Software

    This device is expected to be used for the static 12-lead ECG to detect whether there are abnormal ECG signals related to diseases and outputs the results.

    Also known as: CGMH-EAD-001

06

What researchers measure

Primary outcomes

  1. Sensitivity and Specificity

    The rate of test results that correctly indicate the presence and absence.

    Time frame: baseline

Secondary outcomes

  1. Area Under the receiver operating characteristic Curve

    A graphical plot that illustrates the diagnostic ability of a binary classifier system as its discrimination threshold is varied.

    Time frame: Baseline

07

Study locations

1 site
08

References and documents

Publications

  • Malik J, Devecioglu OC, Kiranyaz S, Ince T, Gabbouj M. Real-Time Patient-Specific ECG Classification by 1D Self-Operational Neural Networks. IEEE Trans Biomed Eng. 2022 May;69(5):1788-1801. doi: 10.1109/TBME.2021.3135622. Epub 2022 Apr 21. PubMed 34910628 ↗
  • Acharya U.R., Fujita H., Lih O.S., Adam M., Tan J.H., Chua C.K. Automated detection of coronary artery disease using different durations of ECG segments with convolutional neu-ral network Knowl.-Based Syst., 132 (sep.15) (2017), pp. 62-71
  • Bos JM, Attia ZI, Albert DE, Noseworthy PA, Friedman PA, Ackerman MJ. Use of Artificial Intelligence and Deep Neural Networks in Evaluation of Patients With Electrocardiographically Concealed Long QT Syndrome From the Surface 12-Lead Electrocardiogram. JAMA Cardiol. 2021 May 1;6(5):532-538. doi: 10.1001/jamacardio.2020.7422. PubMed 33566059 ↗
  • Ribeiro AH, Ribeiro MH, Paixao GMM, Oliveira DM, Gomes PR, Canazart JA, Ferreira MPS, Andersson CR, Macfarlane PW, Meira W Jr, Schon TB, Ribeiro ALP. Automatic diagnosis of the 12-lead ECG using a deep neural network. Nat Commun. 2020 Apr 9;11(1):1760. doi: 10.1038/s41467-020-15432-4. Erratum In: Nat Commun. 2020 May 1;11(1):2227. doi: 10.1038/s41467-020-16172-1. PubMed 32273514 ↗
  • U. Rajendra Acharya, Hamido Fujita, Oh Shu Lih, Yuki Hagiwara, Jen Hong Tan, Muhammad Adam, Automated detection of arrhythmias using different intervals of tachycardia ECG seg-ments with convolutional neural network, Information Sciences, Volume 405, 2017, Pages 81-90, ISSN 0020-0255
  • Jeong DU, Lim KM. Convolutional neural network for classification of eight types of arrhythmia using 2D time-frequency feature map from standard 12-lead electrocardiogram. Sci Rep. 2021 Oct 14;11(1):20396. doi: 10.1038/s41598-021-99975-6. PubMed 34650175 ↗
  • Kwon JM, Jeon KH, Kim HM, Kim MJ, Lim SM, Kim KH, Song PS, Park J, Choi RK, Oh BH. Comparing the performance of artificial intelligence and conventional diagnosis criteria for detecting left ventricular hypertrophy using electrocardiography. Europace. 2020 Mar 1;22(3):412-419. doi: 10.1093/europace/euz324. PubMed 31800031 ↗
  • Makimoto H, Hockmann M, Lin T, Glockner D, Gerguri S, Clasen L, Schmidt J, Assadi-Schmidt A, Bejinariu A, Muller P, Angendohr S, Babady M, Brinkmeyer C, Makimoto A, Kelm M. Performance of a convolutional neural network derived from an ECG database in recognizing myocardial infarction. Sci Rep. 2020 May 21;10(1):8445. doi: 10.1038/s41598-020-65105-x. PubMed 32439873 ↗

Individual participant data

Plan to share: No

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2023 (actual). Primary completion is estimated for Jan 2024, 3 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 6, 2023
First posted
Jun 15, 2023
StartActual
Oct 6, 2023
Primary completionEst.
Jan 31, 2024
CompletionEst.
Feb 28, 2024
Last update
Jan 11, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 11, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05903313
Responsible party
Sponsor
First posted
Jun 15, 2023
Start date
Oct 6, 2023
Primary completion
Jan 31, 2024 (estimated)
Completion
Feb 28, 2024 (estimated)
Last update
Jan 11, 2024

Study contacts

Chang-Fu Kuo, MD/Ph.D
study chair · Associate Professor and Director Division of Rheumatology

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion